Experimental KRAS Vaccine Stimulates Immune Response in High-Risk Pancreatic Cancer Patients
Researchers at Johns Hopkins Kimmel Cancer Center and the Skip Viragh Center for Pancreatic Cancer report early results from a preventive strategy aimed at mutant...















